Table 1.

Characteristics of overall hospitalized cohort (N = 300).

	Overall cohort, N = 300
Male	283 (94.3)
Female	17 (5.7)
Age, 18–44	31 (10.3)
Age, 45–64	73 (24.3)
Age, 65–74	109 (36.3)
Age, 75–84	60 (20.0)
Age, 85 or older	27 (9.0)
American Indian or Alaska Native	3 (1.0)
Asian	2 (0.7)
Black or African American	74 (24.7)
White	202 (67.3)
Native Hawaiian or other Pacific Islander	2 (0.7)
More than one race	2 (0.7)
Unknown	15 (5.0)
Hispanic or Latino ethnicity (regardless of race)	20 (6.7)
Married	131 (43.7)
Urban	220 (73.3)
Rural	64 (21.3)
Highly rural	7 (2.3)
Unknown	9 (3.0)
Prior history of COVID-19	8 (2.7)
Hypertension	213 (71.0)
CHF	56 (18.7)
IHD	78 (26.0)
Diabetes	115 (38.3)
Stroke TIA	18 (6.0)
COPD Bronchiectasis	63 (21.0)
Cirrhosis	10 (3.3)
Dementia	27 (9.0)
Dialysis	12 (4.0)
Cancer-solid organ	20 (6.7)
Cancer-lymphoma leukemia	11 (3.7)
Cancer-other	6 (2.0)
Current smoker	71 (23.7)
Alcohol use disorder	45 (15.0)
Substance use disorder	40 (13.3)
Housing problems	34 (11.3)
BMI, < 18.5	3 (1.0)
BMI, 18.5–24.9	52 (17.3)
BMI, 25–29.9	96 (32.0)
BMI, >  = 30	111 (37.0)
Unknown BMI	38 (12.7)
No Chronic kidney disease	204 (68.0)
Chronic kidney disease	76 (25.3)
Severe chronic kidney disease	20 (6.7)
VA district, Continental	49 (16.3)
VA district, Midwest	51 (17.0)
VA district, North Atlantic	69 (23.0)
VA district, Pacific	63 (21.0)
VA district, Southeast	68 (22.7)
Hospitalization 0–15 days post infection	280 (93.3)
Unvaccinated	127 (42.3)
Vaccinated-not boosted	99 (33.0)
Boosted	69 (23.0)
Vaccinated Status unclear	5 (1.7)
Age >  = 65 and no high-risk conditions	21 (7.0)
High-risk co-morbid conditions (not immunocompromised),	198 (66.0)
Immunocompromised	67 (22.3)